Compare · Healthcare
Apollo Hospitals vs Max Healthcare: how their businesses differ
The same facts for both companies, in the same order, from each company's own page and filings. It is not a ranking.
How they differ
In FY26, Apollo Hospitals' revenue of ₹24,774 cr was about 3 times Max Healthcare's ₹8,373 cr (Cityfort calculation: one divided by the other).
Apollo Hospitals' largest segment is Hospitals, 50.1% of revenue in FY26.
Apollo Hospitals' largest payer group is Hospital patients, their insurers and government schemes, 50.1% of revenue (FY26); Max Healthcare's largest payer group is Self-paying patients and insurers or employers, 71.4% of revenue (Q2 FY27).
Max Healthcare's page lists Apollo Hospitals among its competitors; Apollo Hospitals' page does not list Max Healthcare.
Sources: Apollo Hospitals S4, S7, S1, S22, S18 · Max Healthcare S1, S11, S23, S21
Each company in 5 points
Apollo Hospitals
1 · What it sells
Apollo Hospitals runs 48 hospitals of its own with 8,522 operating beds, supplies 7,662 Apollo pharmacy stores and runs clinics and diagnostic centres, and its Q2 FY27 revenue was ₹7,615 crore.
Sources and detail on the Apollo Hospitals page2 · Who pays it
In FY26, hospital patients and their insurers paid for 50.1% of Apollo's segment revenue, pharmacy stores and online medicine buyers 42.5%, and clinic and diagnostics patients 7.3%.
Sources and detail on the Apollo Hospitals page3 · What it keeps from ₹100
Of every ₹100 that came in during FY26, as first reported, Apollo spent ₹51.4 on medicines and supplies and ₹11.8 on employees, and kept ₹7.6 as profit for shareholders.
Sources and detail on the Apollo Hospitals page4 · Where the operating profit comes from
Hospitals earned ₹2,430 crore of Apollo's ₹2,893 crore FY26 segment profit before interest and tax, or 84.0%, against ₹399 crore from pharmacy and Apollo 24/7 and ₹72 crore from clinics and diagnostics.
Sources and detail on the Apollo Hospitals page5 · The one thing to watch
Apollo plans to move pharmacy and Apollo 24/7, 42.5% of FY26 segment revenue, into the separately listed Apollo Healthtech, and management said on 5 Nov 2026 it expects the demerger in Q4 FY27.
Sources and detail on the Apollo Hospitals page
Max Healthcare
1 · What it sells
Max Healthcare runs private hospitals, mainly in metro cities, with 5,518 operational beds in its network (incl. partner hospitals) on 30 Sep 2026, and its FY26 consolidated revenue was ₹8,373 crore.
Sources and detail on the Max Healthcare page2 · Who pays it
In Q2 FY27, self-paying patients and insurers or employers together paid 71.4% of network hospital revenue, government and institutional schemes 18.4% and international patients 10.2%, and the split between self-pay and insurance is not available on this page.
Sources and detail on the Max Healthcare page3 · What it keeps from ₹100
Of every ₹100 that came in during FY26, Max Healthcare kept ₹16.9 as profit, helped by a one-time tax gain of about ₹142 crore net (about ₹149 crore booked in Q2 FY26, about ₹7 crore reversed in Q4 FY26), while its operating profit before interest, tax and depreciation (EBITDA) was ₹26.2 per ₹100 of revenue.
Sources and detail on the Max Healthcare page4 · Where the operating profit comes from
Max Healthcare reports a single business segment, medical and healthcare services in India, so its FY26 EBITDA of ₹2,195 crore came from hospital care, diagnostics and home care together.
Sources and detail on the Max Healthcare page5 · The one thing to watch
Network operational beds rose to 5,518 on 30 Sep 2026 from 4,760 a year earlier, while borrowings excluding leases rose from ₹565 crore on 31 Mar 2023 to ₹2,907 crore on 31 Mar 2026.
Sources and detail on the Max Healthcare page
Where each ₹100 went
Each company's own receipt for its latest full financial year, with matching lines in the same order where both have them.
Apollo Hospitals
Where ₹100 went · FY26
| Employees | ₹11.8 |
|---|---|
| Depreciation and interest | ₹5.2 |
| Medicines, consumables and goods for resale | ₹51.4 |
| Other running costs | ₹21.2 |
| One-off charge and minority share, less part-owned companies' profit | ₹0.1 |
| Income tax | ₹2.6 |
| Kept as profit for shareholders | ₹7.6 |
| Total | ₹100 |
Of every ₹100 that came in during FY26 (₹25,229 crore of revenue as first reported, including Cradle and Fertility, plus ₹192 crore of other income), Apollo kept ₹7.6 as profit for its shareholders. Each line = amount ÷ ₹25,420 crore × 100 (Cityfort calculation from the FY26 results).
Max Healthcare
Where ₹100 went · FY26
| Employees | ₹15.9 |
|---|---|
| Depreciation and interest | ₹8.0 |
| Drugs, consumables and implants | ₹21.0 |
| Doctors' fees | ₹21.0 |
| Other running costs and one-offs | ₹14.5 |
| Income tax | ₹2.7 |
| Kept as profit | ₹16.9 |
| Total | ₹100 |
Cityfort calculation from the FY26 annual report: each line ÷ total money in (revenue ₹8,373 crore + other income ₹163 crore) × 100. Tax is low because FY26 includes a one-time tax gain of about ₹142 crore net (about ₹149 crore in Q2 FY26, less about ₹7 crore reversed in Q4 FY26).
Line items differ because each company groups its costs its own way in its filings. Only on Apollo Hospitals' receipt: Medicines, consumables and goods for resale; Other running costs; One-off charge and minority share, less part-owned companies' profit; Kept as profit for shareholders. Only on Max Healthcare's receipt: Drugs, consumables and implants; Doctors' fees; Other running costs and one-offs; Kept as profit.
Sources: Apollo Hospitals S4, S7, S1 · Max Healthcare S1, S11, S23
Revenue, net profit and free cash flow
Up to five financial years for each company, drawn on one shared scale per measure. Amounts in ₹ crore as each company reports them.
Revenue
Apollo Hospitals
Max Healthcare
See the numbers
Net profit
Apollo Hospitals
Max Healthcare
See the numbers
Free cash flow
Apollo Hospitals
Max Healthcare
See the numbers
Sources: Apollo Hospitals S17, S16, S15, S11, S4, S7, S1 · Max Healthcare S4, S20, S3, S19, S2, S18, S1, S11, S23
Growth and net margin, FY22 to FY26
Worked out over the years both pages cover, so the two growth figures use the same span. Net margin is net profit as a share of revenue, as on each page.
Apollo Hospitals
- Revenue, per year
- +14.0%
- Net profit, per year
- +16.5%
Max Healthcare
- Revenue, per year
- +20.8%
- Net profit, per year
- +24.3%
Cityfort calculation: compound growth per year from FY22 to FY26 (4 years), from each page's yearly numbers, as reported.
Net margin by year
Sources: Apollo Hospitals S17, S16, S15, S11, S4, S7, S1 · Max Healthcare S4, S20, S3, S19, S2, S18, S1, S11, S23
Latest quarter, against the same quarter a year earlier
Each page's latest quarter as reported; the change is a Cityfort calculation.
Apollo Hospitals
Q2 FY27, the quarter to 30 Sep 2026, against Q2 FY26
| Measure | Q2 FY27 | Q2 FY26 | Change |
|---|---|---|---|
| Revenue | ₹7,615 cr | ₹6,189 cr | +23.0% |
| Net profit | ₹630 cr | ₹477 cr | +32.1% |
Max Healthcare
Q2 FY27, the quarter to 30 Sep 2026, against Q2 FY26
| Measure | Q2 FY27 | Q2 FY26 | Change |
|---|---|---|---|
| Revenue | ₹2,569 cr | ₹2,135 cr | +20.3% |
| Net profit | ₹415 cr | ₹491 cr | −15.5% |
Sources: Apollo Hospitals S18, S9, S8, S7, S4, S6, S5 · Max Healthcare S14, S13, S12, S11, S10, S8, S9, S7, S6
Who pays each company
Apollo Hospitals
- Hospital patients, their insurers and government schemes · 50.1% of revenuePay for treatment in Apollo's hospitals. Management said insurance and self-paying patients gave 82% of inpatient revenue in Q2 FY27; the company's other payer groups are public-sector and government payers, and international patients.
- Pharmacy stores and online medicine buyers · 42.5% of revenueApollo HealthCo's revenue from supplying Apollo pharmacy stores and from online sales through Apollo 24/7. Offline pharmacy distribution was ₹2,885 crore of its ₹3,286 crore revenue in Q2 FY27.
- Clinic, diagnostics and day-surgery patients · 7.3% of revenueAHLL's revenue. In Q2 FY27, diagnostics brought in ₹227 crore, primary care ₹139 crore and specialty care ₹84 crore.
Max Healthcare
- Self-paying patients and insurers or employers · 71.4% of revenuePatients who pay themselves, or whose health insurer or employer pays. The company's chart does not let this page split the two, so they are shown together.
- Government and institutional schemes · 18.4% of revenueSchemes such as CGHS (central government staff) and ECHS (ex-servicemen). Their share fell from 21.5% a year earlier, after CGHS and ECHS disempanelled certain hospitals.
- International patients · 10.2% of revenuePatients who travel from other countries for treatment. Their share rose from 9.2% a year earlier.
Revenue by segment
Apollo Hospitals
FY26
| Segment | Revenue | Share |
|---|---|---|
| Hospitals | ₹12,750 cr | 50.1% |
| Pharmacy and Apollo 24/7 | ₹10,808 cr | 42.5% |
| Clinics and diagnostics | ₹1,865 cr | 7.3% |
Max Healthcare
Not on the Max Healthcare page.
Sources: Apollo Hospitals S7
Borrowings and cash
Apollo Hospitals
- Borrowings
- ₹5,595 cr
- Cash and investments
- ₹2,381 cr
On 30 Sep 2026.
On 30 Sep 2026 Apollo's reported borrowings were ₹3,214 crore more than its cash and short-term investments; part of those borrowings are preference shares that convert into shares, not repayments.
Max Healthcare
- Borrowings
- ₹2,907 cr
- Cash and investments
- ₹701 cr
On 31 Mar 2026.
On 31 Mar 2026 net debt of ₹2,206 crore was about 1.4 times FY26 operating cash flow of ₹1,633 crore (Cityfort calculation from the FY26 annual report).
Sources: Apollo Hospitals S5, S1, S18 · Max Healthcare S1, S7, S21, S23, S31
Who owns each company
Apollo Hospitals
- Promoters: 28.0%
- Foreign institutional investors (FIIs): 43.2%
- Indian institutions (DIIs): 22.1%
- Public: 6.5%
- State governments: 0.2%
- Pledged: 2.9% of the promoter holding.
- Shareholding pattern at the end of Q2 FY27.
Max Healthcare
- Promoters: 23.7%
- Foreign institutional investors (FIIs): 40.5%
- Indian institutions (DIIs): 31.0%
- Public: 4.8%
- Pledged: 0.0% of the promoter holding.
- Shareholding pattern at the end of Q2 FY27.
Sources: Apollo Hospitals S26, S27, S28, S29, S30, S31, S32, S33, S34, S35, S36, S37 · Max Healthcare S33, S34, S35, S36, S37, S38, S39, S40, S41, S42, S43, S44
What protects each business
What each page lists as protecting the business from competitors, each with its written reason. These describe business traits, not the share.
Apollo Hospitals
- Hospital network
48 hospitals of its own and 6 managed ones on 30 Sep 2026. Its biggest regions by operating beds are Tamil Nadu (2,005), the east (1,983) and Andhra Pradesh and Telangana (1,447).
- Complex-care mix
Heart, cancer, brain, gut, bone and transplant care were 61% of inpatient revenue in Q2 FY27. CRISIL says Apollo's revenue per operating bed is among the highest in the industry.
- Pharmacy reach
Apollo HealthCo supplied 7,662 Apollo pharmacy stores on 30 Sep 2026, after adding 223 in Q2 FY27.
- Finances
ICRA assigned [ICRA]AAA (Stable) on 18 May 2026. Operating cash flow was ₹2,856 crore in FY26.
Max Healthcare
- Hospitals in big cities
About 73% of beds are in metro markets (FY26 annual report). CARE puts over 75% of network bed capacity in metros, especially Delhi NCR.
- Complex treatments
The company reports about 4,978 liver, 6,329 kidney and 2,348 bone-marrow transplants done to date.
- Steady bed occupancy
Network occupancy was between 74% and 77% in each quarter from Q3 FY25 to Q2 FY27, while beds were added.
- Patients from abroad
International patients were 10.2% of network hospital revenue in Q2 FY27, up from 9.2% a year earlier.
- Access to borrowing
CARE reaffirmed its AA+ (Stable) rating on Max's long-term bank facilities in Oct 2026, and assessed its liquidity as "Strong" in Oct 2025.
Sources: Apollo Hospitals S18, S22, S38, S39, S7 · Max Healthcare S1, S45, S21, S22, S23, S24, S25, S26, S46
Where growth could come from
Each page's growth drivers. The status compares progress with what the company itself said it would do; it is not a view on the share.
Apollo Hospitals
- Established hospitals · Working: on track against what the company saidRevenue ₹3,765 crore, +19%, Q2 FY27
- New hospitals · Early: too early to judge520 of 1,395 census beds open, Sep 2026
- Patients from abroad · Working: on track against what the company saidInternational patient revenue +37%, Q2 FY27
- Pharmacy and Apollo 24/7 · Working: on track against what the company saidApollo HealthCo revenue ₹3,286 crore, +23%, Q2 FY27
- Clinics and diagnostics · Working: on track against what the company saidAHLL revenue ₹429 crore, +20%, Q2 FY27
- Apollo Healthtech listing · Early: too early to judgeShareholders approved 24 Jun 2026; tribunal sanction pending
Max Healthcare
- New towers at existing hospitals · Working: on track against what the company saidNetwork operational beds 5,518 on 30 Sep 2026, up from 4,760
- New hospital at Sector-56, Gurgaon · Behind: behind the company's own plan500 beds; first phase moved from H1 FY27 to the end of FY27
- Bought hospitals: Bhubaneswar · Early: too early to judgeQ2 FY27 revenue ₹38 crore, EBITDA ₹4 crore
- Patients from abroad · Working: on track against what the company said₹307 crore in Q2 FY27, up from ₹231 crore
- Home care and diagnostics · Working: on track against what the company saidMax@Home ₹86 crore in Q2 FY27, up 37%
- New hospitals in Lucknow and Pune · New: recently announcedAbout ₹1,400 crore approved for about 712 beds, 21 May 2026
Sources: Apollo Hospitals S22, S18, S40, S49, S38 · Max Healthcare S21, S25, S23, S29, S32, S10, S49, S30, S52
Dividends, buybacks, auditor and credit rating
Dividends per share and buybacks for up to five years, the statutory auditor and the latest credit rating, as each page records them.
Apollo Hospitals
- Dividends per shareFY24: ₹16.00 (25.6% of profit) · FY25: ₹19.00 (18.9% of profit) · FY26: ₹20.00 (14.8% of profit)
- BuybacksNone on the page in the last five years.
- AuditorDeloitte Haskins & Sells LLP
- Credit ratingICRA: [ICRA]AAA (long term), [ICRA]A1+ (short term), outlook Stable (18 May 2026)
Max Healthcare
- Dividends per shareFY23: ₹1.00 (8.8% of profit) · FY24: ₹1.50 (13.8% of profit) · FY25: ₹1.50 (13.6% of profit) · FY26: ₹2.00 (13.5% of profit)
- BuybacksNone on the page in the last five years.
- AuditorS.R. Batliboi & Co. LLP, since 2025
- Credit ratingCARE Ratings: CARE AA+ (long-term bank facilities), CARE A1+ (short-term), outlook Stable (8 Oct 2026)
Sources: Apollo Hospitals S53, S15, S11, S1, S7, S39 · Max Healthcare S3, S2, S10, S1, S55, S46, S45
Risks only one page tracks
Risks whose type the other company's page does not list. Both pages track risks of these types: execution, regulation, governance, legal cases. Every risk is on each company's page.
Apollo Hospitals
Every risk type on the Apollo Hospitals page also appears on the other page.
Max Healthcare
- Most beds in one region (customer or supplier concentration)Hospitals in the Delhi region had 2,676 of 5,518 operational network beds in Q2 FY27. CARE names concentration in metros, especially Delhi NCR, as a weakness.
- Payers can drop hospitals from their lists (demand)CGHS and ECHS disempanelled certain Max hospitals, and their share of network hospital revenue fell from 21.5% to 18.4% in a year. In Q2 FY26 cashless service for some standalone health insurers' customers was disrupted, the company says.
- Rising borrowings (debt)Borrowings excluding leases rose from ₹565 crore on 31 Mar 2023 to ₹2,907 crore on 31 Mar 2026. FY26 free cash flow was ₹149 crore.
- Competition from other hospital chains (competition)CARE describes high competition from established brands such as Fortis, Apollo and Medanta. Rivals adding beds in the same cities could slow how fast new Max beds fill.
Key facts
- How does Apollo Hospitals make money compared with Max Healthcare?
- Apollo Hospitals' revenue by segment in FY26: Hospitals 50.1%, Pharmacy and Apollo 24/7 42.5%, Clinics and diagnostics 7.3%. Max Healthcare's revenue by payer: Self-paying patients and insurers or employers 71.4%, Government and institutional schemes 18.4%, International patients 10.2%.
- Which is bigger by revenue, Apollo Hospitals or Max Healthcare?
- Apollo Hospitals reported revenue of ₹24,774 cr in FY26, and Max Healthcare reported revenue of ₹8,373 cr in FY26.
- How much net profit did Apollo Hospitals and Max Healthcare report?
- Apollo Hospitals reported a net profit of ₹1,942 cr in FY26, and Max Healthcare reported ₹1,442 cr in FY26.
- How much of every ₹100 did Apollo Hospitals and Max Healthcare keep as profit?
- Apollo Hospitals kept ₹7.6 of every ₹100 that came in during FY26, and Max Healthcare kept ₹16.9 in FY26 (Cityfort calculation from each company's annual report).
- How much do Apollo Hospitals and Max Healthcare owe, and how much cash do they hold?
- Apollo Hospitals had borrowings of ₹5,595 cr and cash and investments of ₹2,381 cr on 30 Sep 2026. Max Healthcare had borrowings of ₹2,907 cr and cash and investments of ₹701 cr on 31 Mar 2026.
- Who owns Apollo Hospitals and Max Healthcare?
- Promoters held 28.0% of Apollo Hospitals' shares at the end of Q2 FY27, and 2.9% of the promoter holding was pledged. Promoters held 23.7% of Max Healthcare's shares at the end of Q2 FY27, with none of it pledged. Both come from the shareholding patterns the companies filed with NSE and BSE.
- When do Apollo Hospitals' and Max Healthcare's financial years end?
- Apollo Hospitals and Max Healthcare both use the Indian financial year, April to March. The latest full year is FY26 on the Apollo Hospitals page and FY26 on the Max Healthcare page.
Sources: Apollo Hospitals S17, S16, S15, S11, S4, S7, S1, S22, S18, S5 · Max Healthcare S4, S20, S3, S19, S2, S18, S1, S11, S23, S21, S7, S31
Built from each company's page. Apollo Hospitals updated 11 Nov 2026; Max Healthcare updated 11 Nov 2026.
Sources
Apollo Hospitals
- S1Annual Report FY26 (updated version, re-filed 28 Aug 2026), Apollo Hospitals Enterprise Ltd (filed with NSE), 28 Aug 2026
- S4Q2 FY27 results: outcome of board meeting, unaudited results, notes, change in senior management (4 Nov 2026), Apollo Hospitals Enterprise Ltd (filed with NSE), 4 Nov 2026
- S5Q2 FY27 consolidated results, XBRL (integrated filing), NSE (company XBRL filing), 4 Nov 2026
- S6Q1 FY27 consolidated results, XBRL (integrated filing), NSE (company XBRL filing), 12 Aug 2026
- S7Q4 FY26 and FY26 audited consolidated results, XBRL (integrated filing), NSE (company XBRL filing), 20 May 2026
- S8Q3 FY26 consolidated results, XBRL (integrated filing), NSE (company XBRL filing), 10 Feb 2026
- S9Q2 FY26 consolidated results, XBRL (integrated filing), NSE (company XBRL filing), 6 Nov 2025
- S11Q4 FY25 and FY25 audited consolidated results, XBRL (integrated filing), NSE (company XBRL filing), 30 May 2025
- S15Q4 FY24 and FY24 audited consolidated results, XBRL, NSE (company XBRL filing), 31 May 2024
- S16Q4 FY23 and FY23 audited consolidated results, XBRL, NSE (company XBRL filing), 31 May 2023
- S17Q4 FY22 and FY22 audited consolidated results, XBRL, NSE (company XBRL filing), 26 May 2022
- S18Earnings update Q2 FY27 (investor presentation), Apollo Hospitals Enterprise Ltd (filed with NSE), 4 Nov 2026
- S22Transcript of Q2 FY27 earnings call (5 Nov 2026), Apollo Hospitals Enterprise Ltd (company site; link filed with NSE 11 Nov 2026), 11 Nov 2026
- S26Shareholding pattern, quarter ended Sep 2026 (XBRL), NSE (company XBRL filing), 7 Oct 2026
- S27Shareholding pattern, quarter ended Jun 2026 (XBRL), NSE (company XBRL filing), 3 Jul 2026
- S28Shareholding pattern, quarter ended Mar 2026 (XBRL), NSE (company XBRL filing), 9 Apr 2026
- S29Shareholding pattern, quarter ended Dec 2025 (XBRL), NSE (company XBRL filing), 6 Jan 2026
- S30Shareholding pattern, quarter ended Sep 2025 (XBRL), NSE (company XBRL filing), 8 Oct 2025
- S31Shareholding pattern, quarter ended Jun 2025 (XBRL), NSE (company XBRL filing), 8 Jul 2025
- S32Shareholding pattern, quarter ended Mar 2025 (XBRL), NSE (company XBRL filing), 10 Apr 2025
- S33Shareholding pattern, quarter ended Dec 2024 (XBRL), NSE (company XBRL filing), 16 Jan 2025
- S34Shareholding pattern, quarter ended Sep 2024 (XBRL), NSE (company XBRL filing), 9 Oct 2024
- S35Shareholding pattern, quarter ended Jun 2024 (XBRL), NSE (company XBRL filing), 9 Jul 2024
- S36Shareholding pattern, quarter ended Mar 2024 (XBRL), NSE (company XBRL filing), 8 Apr 2024
- S37Shareholding pattern, quarter ended Dec 2023 (XBRL), NSE (company XBRL filing), 5 Jan 2024
- S38Crisil Ratings rating rationale: AHEL bank facilities and NCDs, CRISIL AA+/Positive and CRISIL A1+ (filed with NSE 27 Jan 2026), Crisil Ratings Ltd (letter filed by the company with NSE), 27 Jan 2026
- S39ICRA rating letter: [ICRA]AAA (Stable) and [ICRA]A1+ assigned on Rs 3,000 crore of facilities (letter dated 18 May 2026), ICRA Ltd (letter filed by the company with NSE), 19 May 2026
- S40Board approves composite scheme: demerger of omni-channel pharmacy and digital health into Apollo Healthtech Ltd, amalgamation of Apollo HealthCo and Keimed, listing (30 Jun 2025), Apollo Hospitals Enterprise Ltd (filed with NSE), 30 Jun 2025
- S49Proceedings of the NCLT-convened meeting of equity shareholders on the composite scheme (24 Jun 2026), Apollo Hospitals Enterprise Ltd (filed with NSE), 24 Jun 2026
- S53NSE corporate announcements list for APOLLOHOSP (dividend and record-date entries, Feb 2023 - Nov 2026), National Stock Exchange of India, 11 Nov 2026
Max Healthcare
- S1Integrated Annual Report FY26, Max Healthcare Institute Ltd (filed with NSE/BSE), 8 Jul 2026
- S2Annual Report FY25, Max Healthcare Institute Ltd (filed with NSE/BSE), 4 Jul 2025
- S3Annual Report FY24, Max Healthcare Institute Ltd (filed with NSE/BSE), 26 Aug 2024
- S4Annual Report FY23, Max Healthcare Institute Ltd (filed with NSE/BSE), 4 Sep 2023
- S6Q2 FY27 results (board outcome, quarter and half-year ended 30 Sep 2026), Max Healthcare Institute Ltd (filed with NSE/BSE), 30 Oct 2026
- S7Q2 FY27 consolidated results, XBRL (integrated filing), Max Healthcare Institute Ltd (filed with NSE/BSE), 30 Oct 2026
- S8Q1 FY27 results (board outcome, quarter ended 30 Jun 2026), Max Healthcare Institute Ltd (filed with NSE/BSE), 13 Aug 2026
- S9Q1 FY27 consolidated results, XBRL (integrated filing), Max Healthcare Institute Ltd (filed with NSE/BSE), 13 Aug 2026
- S10Q4 FY26 and FY26 audited results (board outcome 21 May 2026; also dividend, Lucknow capex, registered-office shift), Max Healthcare Institute Ltd (filed with NSE/BSE), 21 May 2026
- S11Q4 FY26 / FY26 consolidated results, XBRL (integrated filing), Max Healthcare Institute Ltd (filed with NSE/BSE), 21 May 2026
- S12Q3 FY26 results (board outcome, quarter ended 31 Dec 2025), Max Healthcare Institute Ltd (filed with NSE/BSE), 5 Feb 2026
- S13Q3 FY26 consolidated results, XBRL (integrated filing), Max Healthcare Institute Ltd (filed with NSE/BSE), 5 Feb 2026
- S14Q2 FY26 consolidated results, XBRL (integrated filing), Max Healthcare Institute Ltd (filed with NSE/BSE), 14 Nov 2025
- S18Q4 FY24 / FY24 consolidated results, XBRL (cross-check of FY24), Max Healthcare Institute Ltd (filed with NSE/BSE), 22 May 2024
- S19Q4 FY23 / FY23 consolidated results, XBRL (cross-check of FY23), Max Healthcare Institute Ltd (filed with NSE/BSE), 17 May 2023
- S20Q4 FY22 / FY22 consolidated results, XBRL (FY22 as first reported), Max Healthcare Institute Ltd (filed with NSE/BSE), 26 May 2022
- S21Press release and Earnings Update, Q2 FY27, Max Healthcare Institute Ltd (filed with NSE/BSE), 30 Oct 2026
- S22Press release and Earnings Update, Q1 FY27, Max Healthcare Institute Ltd (filed with NSE/BSE), 13 Aug 2026
- S23Press release and Earnings Update, Q4 FY26, Max Healthcare Institute Ltd (filed with NSE/BSE), 21 May 2026
- S24Press release and Earnings Update, Q3 FY26, Max Healthcare Institute Ltd (filed with NSE/BSE), 5 Feb 2026
- S25Press release and Earnings Update, Q2 FY26, Max Healthcare Institute Ltd (filed with NSE/BSE), 14 Nov 2025
- S26Press release and Earnings Update, Q4 FY25, Max Healthcare Institute Ltd (filed with NSE/BSE), 20 May 2025
- S29Earnings call transcript, Q2 FY27 (call 3 Nov 2026), Max Healthcare Institute Ltd (filed with NSE/BSE), 9 Nov 2026
- S30Earnings call transcript, Q1 FY27 (call 14 Aug 2026), Max Healthcare Institute Ltd (filed with NSE/BSE), 20 Aug 2026
- S31Earnings call transcript, Q4 FY26 (call 22 May 2026), Max Healthcare Institute Ltd (filed with NSE/BSE), 29 May 2026
- S32Earnings call transcript, Q3 FY26 (call 6 Feb 2026), Max Healthcare Institute Ltd (filed with NSE/BSE), 12 Feb 2026
- S33Shareholding pattern as of 30 Sep 2026 (XBRL), Max Healthcare Institute Ltd (filed with NSE/BSE), 16 Oct 2026
- S34Shareholding pattern as of 30 Jun 2026 (XBRL), Max Healthcare Institute Ltd (filed with NSE/BSE), 17 Jul 2026
- S35Shareholding pattern as of 31 Mar 2026 (XBRL), Max Healthcare Institute Ltd (filed with NSE/BSE), 20 Apr 2026
- S36Shareholding pattern as of 31 Dec 2025 (XBRL), Max Healthcare Institute Ltd (filed with NSE/BSE), 15 Jan 2026
- S37Shareholding pattern as of 30 Sep 2025 (XBRL), Max Healthcare Institute Ltd (filed with NSE/BSE), 18 Oct 2025
- S38Shareholding pattern as of 30 Jun 2025 (XBRL), Max Healthcare Institute Ltd (filed with NSE/BSE), 18 Jul 2025
- S39Shareholding pattern as of 31 Mar 2025 (XBRL), Max Healthcare Institute Ltd (filed with NSE/BSE), 15 Apr 2025
- S40Shareholding pattern as of 31 Dec 2024 (XBRL), Max Healthcare Institute Ltd (filed with NSE/BSE), 20 Jan 2025
- S41Shareholding pattern as of 30 Sep 2024 (XBRL), Max Healthcare Institute Ltd (filed with NSE/BSE), 18 Oct 2024
- S42Shareholding pattern as of 30 Jun 2024 (XBRL), Max Healthcare Institute Ltd (filed with NSE/BSE), 16 Jul 2024
- S43Shareholding pattern as of 31 Mar 2024 (XBRL), Max Healthcare Institute Ltd (filed with NSE/BSE), 17 Apr 2024
- S44Shareholding pattern as of 31 Dec 2023 (XBRL), Max Healthcare Institute Ltd (filed with NSE/BSE), 15 Jan 2024
- S45CARE Ratings press release: Max Healthcare Institute Ltd, ratings reaffirmed (10 Oct 2025), CARE Ratings Ltd, 10 Oct 2025
- S46Intimation: CARE reaffirms CARE AA+ (Stable) / CARE A1+ (9 Oct 2026), Max Healthcare Institute Ltd (filed with NSE/BSE), 9 Oct 2026
- S49Infusion of ~Rs 87.87 crore in Kalinga Hospital Ltd via rights issue (3 Sep 2026), Max Healthcare Institute Ltd (filed with NSE/BSE), 3 Sep 2026
- S52SPA to acquire 100% of Yerawada Properties Pvt Ltd (Pune hospital project) (18 Dec 2025), Max Healthcare Institute Ltd (filed with NSE/BSE), 18 Dec 2025
- S55Board outcome 20 May 2025: S.R. Batliboi & Co. LLP appointed statutory auditors (Deloitte term ends), Max Healthcare Institute Ltd (filed with NSE/BSE), 20 May 2025
Disclaimer
For learning only. Cityfort is not a SEBI-registered adviser and does not recommend buying or selling any security. Prices shown are dated and may be out of date.
Investing in securities involves risk, including loss of capital. Before making any investment decision, do your own research and consider consulting a SEBI-registered investment adviser.
Cityfort, its owners and contributors may or may not hold securities of companies covered. Content is not an offer or solicitation to buy or sell any security.
Read the full disclaimerHide the full disclaimer
Cityfort publishes educational content that explains how listed companies work. Cityfort is not registered with the Securities and Exchange Board of India (SEBI) as an Investment Adviser or Research Analyst and does not provide investment advice, recommendations, ratings, price targets or any opinion on whether to buy, sell or hold any security.
All information is taken from publicly available sources, mainly company filings on BSE and NSE, which are listed on each page with dates. We work to keep it accurate and correct errors publicly, but we do not guarantee that it is complete, accurate or up to date. Any market price or price-based ratio shown is dated, may be out of date by the time you read it, and is included only to explain concepts.
Statements by company management are reported as statements, with their date and source; they are not our forecasts.